Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

FD acquires QuantumKDB

12 Jan 2016 07:00

RNS Number : 5189L
First Derivatives PLC
12 January 2016
 

12 January 2016

 

First Derivatives plc

("FD", the "Company" or the "Group")

 

FD acquires QuantumKDB

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces that it has acquired the entire issued share capital of QuantumKDB (UK) Limited ("Quantum") for total consideration of up to £2.2m. The acquisition provides the Group with complementary consultancy expertise to support the growth of its Kx business and is expected to be earnings enhancing in the first full year following acquisition*.

 

Acquisition rationale

 

Quantum was founded in 2011 by its CEO Kieran Lucid and provides Kx consulting in the UK, US and Hong Kong. The majority of its clients operate in capital markets and the acquisition will strengthen the Group's relationship with certain key clients as well as adding to the existing customer base. Quantum has a total of 15 consultants with strong experience in Kx technology. In its latest financial year to 13 September 2015, Quantum reported profit before tax of £0.3m and had net assets of £0.25m at acquisition.

 

Terms of the Acquisition

 

The initial consideration for the acquisition is £1.7m of which £0.6m is payable in cash and £1.1m is payable through the issue of 72,940 new ordinary shares in FD (the "Consideration Shares"). Deferred consideration of up to £0.5m is payable on the achievement of certain targets on the 12 month anniversary of the acquisition.

 

Application has been made for the 72,940 Consideration Shares to be admitted to trading on AIM and ESM and it is expected that admission will take place on 15 January 2016. The Consideration Shares will rank pari passu with the Company's existing ordinary shares in issue. Following this allotment, the total issued share capital of the Company will increase to 23,921,972 ordinary shares.

 

Kieran Lucid, Chief Executive Officer of Quantum, commented: "As the home of Kx technology, FD is a natural fit for us. We are joining at a time of rapid expansion in the Kx client base across industry sectors, as more and more clients appreciate the benefits of this technology that has dominated capital markets for more than 10 years. We are excited about drawing on the expertise we've gained to assist the Group in its ambitious plans for the future."

 

Brian Conlon, Chief Executive Officer of FD, commented: "We are experiencing increasing demand for Kx skills from existing and potential customers and the acquisition of Quantum will add to our existing capabilities and support our growth plans. We welcome its staff to the Group."

 

\* This statement does not constitute a profit forecast.

 

Enquiries

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc

(Nominated Adviser and Broker)

Dominic Emery

Carlton Nelson

Sebastian Lawrence

+44 (0)20 7597 4000

 

 

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

 

 

Walbrook PR

Paul Cornelius / Nick Rome / Helen Cresswell / Sam Allen

 

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAEFFFELKEAF
Date   Source Headline
1st Sep 20091:24 pmRNSExercise of Options
3rd Aug 20094:40 pmRNSDirector/PDMR Shareholding
22nd Jul 20092:42 pmRNSDirector/PDMR Shareholding
23rd Jun 20095:00 pmRNSPassing of AGM Resolutions
23rd Jun 20097:00 amRNSAGM Statement
20th May 200912:50 pmRNSDividend Declaration
20th May 20097:00 amRNSDirectorate Change
20th May 20097:00 amRNSFinal Results
24th Apr 20094:45 pmRNSDirector Declaration
1st Apr 20097:00 amRNSAcquisition
31st Mar 20093:12 pmRNSTotal Voting Rights
31st Mar 20097:00 amRNSIEX Notice
25th Mar 20092:47 pmRNSIssue of Equity
30th Jan 20094:20 pmRNSTotal Voting Rights
29th Jan 200910:07 amRNSNew Investment - Replacement
29th Jan 20099:00 amRNSFinancial Support from Invest NI
26th Jan 20097:00 amRNSOEM License Agreement
23rd Jan 20093:45 pmRNSDirector/PDMR Shareholding
16th Jan 20097:00 amRNSDirectorate Change
9th Jan 20094:11 pmRNSExercise of Options
23rd Oct 20087:30 amRNSNon Regulatory Announcement
9th Oct 20087:00 amRNSInterim Results
30th Sep 20082:23 pmRNSTotal Voting Rights
30th Sep 20087:00 amRNSIssue of Equity
15th Sep 20087:00 amRNSAcquisition
28th Aug 20083:02 pmRNSAnnual Report and Accounts
27th Aug 20087:00 amRNSDirectorate Change
13th Aug 20087:00 amRNSIEX Notice
7th Aug 20084:47 pmRNSIssue of Equity
9th Jul 20087:00 amRNSRe Contract
17th Jun 200812:40 pmRNSAGM Statement
14th May 20087:00 amRNSDirectorate Change
14th May 20087:00 amRNSFinal Results
7th May 20084:22 pmRNSNotice of Results
30th Apr 20081:39 pmRNSTotal Voting Rights
29th Feb 20082:41 pmRNSIssue of Equity
28th Feb 20087:00 amRNSTrading Statement
1st Feb 20084:17 pmRNSResult of EGM
30th Nov 200711:33 amRNSTotal Voting Rights
21st Nov 20075:01 pmRNSDirector/PDMR Shareholding
14th Nov 20071:17 pmRNSIssue of Equity
9th Nov 20074:45 pmRNSDirector/PDMR Shareholding
9th Nov 20074:42 pmRNSDirector/PDMR Shareholding
1st Nov 200710:33 amRNSTotal Voting Rights
4th Oct 20075:27 pmRNSInterim Results - Replacement
4th Oct 20077:01 amRNSInterim Results
28th Sep 20073:01 pmRNSChange of Adviser
23rd Aug 20077:00 amRNSTrading Statement
23rd Aug 20077:00 amRNSTrading Statement
17th Aug 20075:01 pmRNSWebsite Information

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.